Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2008 / N 1

Глюкокортикоид-индуцированный остеопороз (Список литературы)
И.А. Баранова


1. Клинические рекомендации. Остеопороз. Диагностика, профилактика и лечение / Под ред. Л.И. Беневоленской, О.М. Лесняк. - М.: ГЭОТАР-Медиа, 2005. – 176 с.
2. Van Staa T., Leufkens H.G.M., Abenhaim L. et al. Use of oral corticosteroids and risk of fractures // J. Bone Miner. Res. - 2000. -Vol.15. -P.993–1000.
3. Walsh L.J., Wong C., Pringle M., Tattersfield A.E. Use of oral glucocorticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study //BMJ.- 1996.- Vol. 313.- P.344–346.
4. van Staa T.P., Leufkens H.G.M., Abenhaim L., et al. Use of oral glucocorticosteroids in the United Kingdom.// QJM.- 2000.- Vol. 93.-105–111.
5. van Staa T.P., Leufkens H.G.M., Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.// Osteoporos Int.- 2002.- Vol. 13.- P.777–787.
6. Angeli A., Guglielmi G., Dovio A. et al High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. ///Bone.- 2006.- Vol. 39.- P.253–259
7. Kanis J.A., Stevenson M., McCloskey E.V., et al. Glucocorticoid-induced osteoporosis: a systematic review and cost–utility analysis //Health Technology Assessment.- 2007.- Vol. 11: № 7.
8. WHO Study Group «Assesment of fracture risk and its application to screening for postmenopausal osteoporosis».- Geneva: World Health Organization, 1994.
9. Van Staa T.P., Laan R.F., Barton I.P. et al. Bone density threshold and other predictors of vertebral fracture in patients receiving glucocorticoid therapy // Arthritis Rheum. - 2003. -Vol.48, №11. -P.3224-3229.
10. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. 2001 Update. American College of Rheumatology ad hoc committee on glucocorticoid-induced osteoporosis // Arthritis. Rheum. – 2001. – Vol. 44, № 7. – P. 1496–1503.
11. Eastell R., Reid D.M., Compston J.E. et al. A UK consensus group on management of glucocorticoid-induced osteoporosis: an update // J. Intern. Med. – 1998. – Vol. 244. – P. 271–292.
12. Matsumoto H., Ishihara K., Hasegawa T. et al. Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients. A 4-year longitudinal study // Chest. - 2001. – Vol. 120. – P. 1468-1473.
13. Van Staa T.P., Cooper C., Leufkens H.G., Bishop N. Children and the risk of fractures caused by oral corticosteroids // J. Bone Miner. Res. -2003. -Vol.18, № 5. -P. 913-918.
14. Vestergaard P., Olsen ML., Paaske Johnsen S. et al. Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark // J.Intern. - 2003. -Vol. 254, №5. -P. 486-493.
15. Mortimer K.J., Harrison T.W., Tattersfield A.E. Effects of inhaled corticosteroids on bone // Ann. Allergy Asthma Immunol. - 2005. - Vol. 94, № 1. -P. 15-21
16. Mash B., Bheekie A., Jones P.W. Inhaled versus oral steroids for adults with bronchial asthma // The Cochrane Library. – 2002. – Issue 3. - CD002161.
17. Global Strategy for Asthma Management and Prevention // www.ginasthma.org.
18. The Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease // N. Engl. J. Med. – 2000. – Vol. 343. – P. 1902–1909.
19. Jones A., Fay J.K., Burr M. et al. Inhaled corticosteroid effects on bone metabolism in asthma and mild obstructive pulmonary disease // The Cochrane Library. - 2002. - Issue 3. - CD003537.
20. Richy F., Bousquet J., Ehrlich G.E. et al. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systemic review// Osteoporos. Int.- 2003. -Vol. 14, № 3. -P. 179-190.
21. Hubbard R.B., Smith C.J.P., Smeeth L. et al. Inhaled corticosteroids and hip fracture // Am. J. Resp.Crit. Care Med. – 2002. – Vol. 166. – P. 1563-1566.
22. Lee T.A., Weiss K.B. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease // Am. J. Respir. Crit. Care Med. – 2004. – Vol. 169. – P. 855–859.
23. Suissa S., Baltzan M., Kremer R., Ernst P. Inhaled and nasal corticosteroid use and the risk of fracture // Am.J.Respir.Crit.Care.Med. - 2004. -Vol. 169, № 1. -P. 83-88.
24. Health Care Guideline: diagnosis and treatment of osteoporosis. Institute for Clinical System Improvement, 2004. - www.icsi.org.
25. de Vries F., van Staa T.P., Bracke M.S.G.M. et al. Severity of obstructive airway disease and risk of osteoporotic fracture // Eur. Respir. J. - 2005. -Vol. 25. -P. 879-884.
26. Van Staa T.P., Leufkens H.G., Cooper C. Use of inhaled corticosteroids and risk of fractures // J. Bone Miner. Res. -2001. -Vol.16. -P.581-588.
27. Van Staa T.P., Bishop N., Leufkens H.G., Cooper C. Are inhaled corticosteroids associated with an increased risk of fracture in children? // Osteoporos. Int. -2004. -Vol. 15, № 10. - P. 785-791.
28. Gennari C., Imbimbo B. Effects of prednisone and deflazacort on vertebral bone mass // Calcif. Tis. Int. – 1985. – Vol. 37. – P. 592–593.
29. Cranney A., Welch V., Adachi J.D. et al. Calcitonin for the treatment and prevention of coericosteroid-induced osteoporosis // The Cochrane Library. – 2004. - Issue I. - CD 001983.
30. Homic J., Suarez-Almazor M.E., Shea B. et al. Calcium and vitamin D for corticosteroid-induced osteoporosis (Cochrane Review) // The Cochrane Library. – 2004. - Issue I. - CD 000952.
31. Plotkin L.I., Weinstein R.S., Parfitt A.M., Roberson P.K. et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin // J. Clin. Invest. . - 1999 . - Vol.104 . - P.1363–1374.
32. Adachi J.D., Saag K.J., Delmas P.D., et al. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial // Arthritis & Rheumatism. -2001. - Vol. 44, № 1. - P.202-211.
33. Sambrook P.N., Kotowicz M., Nash M. et al. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium // J.Bone Miner.Res.- 2003. -Vol. 18, № 5. -P.919-924.
34. Patlas N, Golomb G, Yaffe P, et al. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats // Teratology. -1999.- Vol.60, № 2.- P.68-73.
35. Knopp J.A., Diner B.M., Blitz M. et al. Calcitonin for treating acute pain of osteopotic compression fractures: a systemic review of randomized, controlled trials // Osteoporos. Int. – 2005. – Vol. 16, № 10. – P. 1281-1290.
36. Richy F, Schacht E, Bruyere O, et al. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.// Calcif Tissue Int. .-2005.- Vol. 76, № 3.- P.176-86.
37. Ringe J.D., Dorst A., Faber H. et al. Superiority of alfacalcidol over plain vaitamin D in the treatment of glucocorticoid-induced osteoporosis // Rheumatol. Int. - 2004. - Vol.24, № 2. -P. 63-70.
38. Reid I.R., Ibbertson H.K., France J.T., Pybus J. Plasma testosterone concentrations in asthmatic men treated with glucocorticoids // BMJ . -1985. - Vol. 291. - P.574.
39. Lukert B.P., Johnson B.E., Robinson R.G. Estrogen and progesterone replacement therapy reduced glucocorticoid-induced bone loss // J.Bone Miner.Res. - 1992. - Vol. 7. - P. 1063-1069.
40. Lane N.E., Sanchez S., Genant H.K. et al. Short-term increase in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with osteoporosis // Osteoporos. Int. – 2000. – Vol. 11. – P. 434-442.
41. Hodsman A.B., Bauer D.C., Dempster D. et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. //Endocr. Rev.- 2005.- Vol. 349.- P. 688-703
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]